We are live on ! Find out more
IMMU

Immunomedics Inc
IMMU

Delisted

IMMU was delisted on the 22nd of October, 2020.

81 hedge funds and large institutions have $135M invested in Immunomedics Inc in 2014 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

25% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 20

7% more funds holding

Funds holding: 7681 (+5)

0% less capital invested

Capital invested by funds: $135M → $135M (-$360K)

15% less call options, than puts

Call options by funds: $3.26M | Put options by funds: $3.85M

Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
2.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
25
Reduced
20
Closed
7
Calls
$3.26M
Puts
$3.85M
Net Calls
-$594K
Net Calls Change
+$897K
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$446K -$21K -6,200 -5%
State Board of Administration of Florida Retirement System
27
State Board of Administration of Florida Retirement System
Florida
$383K
Swiss National Bank
28
Swiss National Bank
Switzerland
$356K
Goldman Sachs
29
Goldman Sachs
New York
$331K +$241K +71,292 +405%
ProShare Advisors
30
ProShare Advisors
Maryland
$301K -$52.7K -15,603 -16%
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$254K
Morgan Stanley
32
Morgan Stanley
New York
$243K -$113K -33,563 -34%
NFA
33
Nationwide Fund Advisors
Ohio
$238K +$2.11K +624 +1%
Wells Fargo
34
Wells Fargo
California
$237K +$146K +43,117 +209%
VOYA Investment Management
35
VOYA Investment Management
Georgia
$229K
MLICM
36
Metropolitan Life Insurance Company (MetLife)
New York
$228K
AIG
37
American International Group
New York
$207K -$135 -40 -0.1%
DekaBank Deutsche Girozentrale
38
DekaBank Deutsche Girozentrale
Germany
$203K +$5.07K +1,500 +3%
Citadel Advisors
39
Citadel Advisors
Florida
$198K +$31.7K +9,382 +21%
BA
40
BlackRock Advisors
Delaware
$197K -$3.08K -912 -2%
DIA
41
Denver Investment Advisors
Colorado
$195K +$10K +2,959 +6%
Public Employees Retirement Association of Colorado
42
Public Employees Retirement Association of Colorado
Colorado
$179K
AQR Capital Management
43
AQR Capital Management
Connecticut
$177K -$123K -36,500 -43%
HCM
44
Highbridge Capital Management
New York
$161K +$146K +43,266 New
T. Rowe Price Associates
45
T. Rowe Price Associates
Maryland
$159K
Barclays
46
Barclays
United Kingdom
$155K -$3.88K -1,148 -2%
PPA
47
Parametric Portfolio Associates
Washington
$150K +$136K +40,319 New
CS
48
Credit Suisse
Switzerland
$147K -$143K -42,248 -52%
UBS AM
49
UBS AM
Illinois
$115K
FHC
50
First Heartland Consultants
Missouri
$114K

IMMU Hedge Fund Activity: Q3 2014 in Review

81 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2014, worth a combined $135M — down 0.27% from $135M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IMMU positions and 7 closed out — a net gain of 5 holders — while 25 added to existing stakes and 20 trimmed.

The largest buyer was Vanguard Group, adding an estimated $383K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.65M sold.

  • 81 institutional investors held Immunomedics Inc (IMMU) as of Q3 2014, up from 76 in Q2 2014.
  • Funds reported $135M of Immunomedics Inc stock for Q3 2014, down 0.27% quarter-over-quarter.
  • 12 funds opened new Immunomedics Inc positions in Q3 2014 and 7 closed out, a net change of +5 holders.
  • The largest Immunomedics Inc buyer in Q3 2014 was Vanguard Group, an estimated $383K added.
  • The largest Immunomedics Inc seller in Q3 2014 was RA Capital Management, an estimated $3.65M sold.

Based on aggregated 13F filings for Q3 2014.